The General Use of Robots in Stroke Recovery: the Anklebot

Description

The purpose of this study is to determine if intensive lower extremity robotic therapy can improve gait speed and functional ambulation status in individuals 6 months or greater post-stroke.

Study Start Date

June 2013

Estimated Completion Date

August 2017

Interventions

  • Device: MIT Anklebot

Specialties

  • Neurology: Stroke/Vascular
  • Physician Assistant: Neurology

MeSH Terms

  • Cerebral Infarction
  • MIT Anklebot
  • Stroke

Study ID

North Shore Long Island Jewish Health System -- 13-310

Status

Unknown

Trial ID

NCT02249832

Study Type

Interventional

Trial Phase

N/A

Enrollment Quota

55

Sponsor

North Shore Long Island Jewish Health System

Inclusion Criteria

  • 18 years of age or older
  • First single focal unilateral lesion with diagnosis verified by brain imaging, which occurred at least 6 months prior
  • Cognitive function sufficient enough to understand experiments and follow instructions
  • Some amount of independent ambulation (with orthoses or walker) and a gait speed of at least 0.4m/s.

Exclusion Criteria

  • Botox treatment within 6-weeks of enrollment
  • Fixed contraction deformity in the affected limb
  • Complete and total flaccid paralysis of all lower extremity motor function
  • Unable to ambulate except with the aid of another person or ambulation speed of <0.4m/s

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (2)

Study Location Distance Name Phone Email
Feinstein Institute for Medical Research - Manhasset, New York 37.0 miles None None None
Transitions of Long Island Outpatient Rehabilitation - Manhasset, New York 37.0 miles None None None

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.